CRAT Antikörper (AA 23-113)
Kurzübersicht für CRAT Antikörper (AA 23-113) (ABIN7112326)
Target
Alle CRAT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 23-113
-
Verwendungszweck
- CRAT antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
-
Immunogen sequence: 23-113aa
Immunogen: carnitine acetyltransferase
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- CRAT (Carnitine O-Acetyltransferase (CRAT))
-
Andere Bezeichnung
- CRAT
-
Hintergrund
-
Synonyms: Carnitine O-acetyltransferase (Carnitine acetylase)|Carnitine acetyltransferase (CAT, CrAT)|CRAT|CAT1
Background: Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria.
-
Molekulargewicht
- 55-68 kDa
-
Gen-ID
- 1384
-
UniProt
- P43155
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-